Germany Diabetes Market Report 2020-2025: Market is Expected to be $12 Billion - Lifestyle-Compatible Treatment Options and Technological Advancement in Insulin Pump Devices
DUBLIN, March 29, 2021 /PRNewswire/ -- The "Germany Diabetes Market, by Continuous Glucose Monitoring (CGM), Blood Glucose (SMBG) Device, Insulin Pen, Insulin Pump, Reimbursement Company Analysis & Forecast" report has been added to ResearchAndMarkets.com's offering.
Germany Diabetes Market is expected to be USD 12 Billion by the end of the year 2025.
Diabetes mellitus is a significant public health problem and one of the biggest challenges for healthcare systems all over Germany. The prevalence of known type 1 & 2 diabetes in the German adult population is very high; also, it is considered that a high number of patients are not yet diagnosed with the disease.
Due to an ageing population and unhealthy lifestyle, the prevalence of type 2 diabetes is expected to increase steadily over the next few years. High-quality care, including adequate monitoring, control of risk factors and active self-management are the key factors for preventing costly and burdensome micro- and macrovascular complications in German patients with type 2 diabetes.
In this report, Germany Diabetic market is segmented into four parts; Insulin Pen, CGM, SMBG, and Insulin Pump. All the four insulin delivery devices segment mentioned above are growing year on year. With the rising incidences of diabetic problems, various digital care solutions have been introduced in the country to help people with diabetes.
Robert Koch Institute (RKI), The German federal disease control and prevention research institute has been developing a public health surveillance system. It focuses on long-term data, collection of comparable and ensuring the establishment of efficient surveillance structures for monitoring relevant indicators of diabetes.
In 2019, a country-wide campaign, called 'Sche1sstyp', was initiated by the Germany-based research centre, Helmholtz Zentrum Munchen. The campaign addresses the prevention and early detection of type 1 diabetes. In June 2019, the 2nd World Conference on Diabetes and Endocrinology was organized in Berlin, which included various research presentations provided by global leaders in diabetes and endocrinology. The Coronavirus (COVID-19) disease has affected the Germany Diabetes market. For people living with diabetes, it is essential to take precautions to avoid the virus if possible.
Key Topics Covered:
1 Introduction
2 Research & Methodology
3 Executive Summary
4 Market Dynamic
4.1 Growth Driver
4.1.1 Rising Diabetes Mellitus in an Aging Population
4.1.2 Rising prevalence of diabetes in various age groups
4.1.3 Rising Government Funding for Diabetes Management
4.1.4 Benefits of Insulin Pump over Multiple Daily Injection
4.1.5 Lifestyle-Compatible Treatment Options and Technological Advancement in Insulin Pump Devices
4.2 Challenges
4.2.1 Technological Advancements in Insulin Infusion Devices
4.2.2 Blood Glucose Meter Accuracy Problem Acknowledged by FDA, Industry & Clinicians
4.2.3 Low Compliance of Glucose Monitoring & Inadequate Reimbursement for SMBG Supplies
4.2.4 Safety Issues in Insulin Pump Devices
4.2.5 Difficulties Associated with the Pump
4.2.5.1 Weight Gain
4.2.5.2 Diabetic Ketoacidosis
4.2.5.3 Infection and Infusion Site Reactions
4.2.6 Adherence
5 Analysis - Germany Diabetic
5.1 Market
6 Population
6.1 Diabetes Population
6.1.1 Type 1
6.1.2 Type 2
7 Market Share Analysis - Germany Diabetic
7.1 By Types
8 CGM Market
8.1 Germany - CGM Market by Components
8.1.1 Glucose Sensor Market & Forecast
8.1.2 CGM Transmitter Market & Forecast
8.2 Germany - CGM User (2011 - 2025)
8.3 CGM Reimbursement in Germany
9 Blood Glucose Device (SMBG)
9.1 Market
9.1.1 Type 1 & Type 2 (Diabetes)
9.2 Test Strips Market and Forecast
9.2.1 Type 1 & Type 2 (Diabetes)
9.3 Lancet Market and Forecast
9.3.1 Type 1 & Type 2 (Diabetes)
9.4 Meter Market and Forecast
9.4.1 Type 1 & Type 2 (Diabetes)
9.5 Blood Glucose (SMBG) Users and Forecast
9.5.1 Type 1 & Type 2 (Diabetes)
9.6 Reimbursement of Blood Glucose Devices in Germany
10 Insulin Pen Market
10.1 Insulin Pen User
10.2 Types - Insulin Pen Market & Users
10.2.1 Disposable Insulin Pen
10.2.1.1 Market
10.2.1.2 User
10.2.2 Reusable Insulin Pen
10.2.2.1 Market
10.2.2.2 User
10.2.3 Smart Insulin Pen
10.2.3.1 Market
10.2.3.2 User
10.3 Insulin Pen Needle Market
10.4 Reimbursement Policies
11 Insulin Pump Market
11.1 Insulin Pump Market
11.1.1 Type 1 & Type 2 (Insulin Pump Market & Forecast)
11.2 Insulin Pump Users
11.2.1 Type 1 & Type 2 (Insulin Pump User & Forecast)
11.3 Reimbursement Policies on Insulin Pump
12 Company Analysis
- B. Braun Melsungen AG
- Eli Lilly and Company
- Artsana S.p.A
- BD
- Novo Nordisk A/S
- Owen Mumford Ltd
- Ypsomed AG
- Medtronic
- Insulet Corporation
- LifeScan Inc.
- Abbott Laboratories
- DEXCOM INC
- Roche
For more information about this report visit https://www.researchandmarkets.com/r/hq1pgm
Media Contact:
Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets
Share this article